Insight

Neuromuscular Training on Chemotherapy-Induced Neuropathy

Photo taken from agebold.com

Jul 8, 2024, 12:42

Neuromuscular Training on Chemotherapy-Induced Neuropathy

Osama Mosalem, a Hematology Oncology fellow at Mayo Clinic, shared a post on X:

“Exercise and risk of neuropathy: 158 patients treated with oxaliplatin or vinca alkaloids did 15-30 min of balance/vibration training. Neuropathy incidence reduced by 50-70% compared to SOC (Standard of Care).”

Preventive Effect of Neuromuscular Training on Chemotherapy-Induced Neuropathy

Authors: Fiona Streckmann, Thomas Elter, Helmar C. Lehmann, Hansjörg Baurecht, Tatjana Nazarenus, Vanessa Oschwald, Christina Koliamitra, Sarah Otten, Andreas Draube, Petra Heinen, Tilman Steinmetz, Michael Hallek, Michael Leitzmann, Wilhelm Bloch, Maryam Balke.

Source: Osama Mosalem/X

Andreas Draube cancer Chemotherapy-Induced Neuropathy Christina Koliamitra Fiona Streckmann Hansjörg Baurecht Helmar C. Lehmann Maryam Balke Mayo Clinic Michael Hallek Michael Leitzmann neuromuscular training OncoDaily Oncology Osama Mosalem oxaliplatin Petra Heinen Sarah Otten Tatjana Nazarenus Thomas Elter Tilman Steinmetz Vanessa Oschwald vinca alkaloids Wilhelm Bloch

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage